Halaven IV injection 1mg, manufactured by Eisai, contains Eribulin mesylate. With YJ code 4291420A1022 and standard 1mg 2mL 1 bottle, it is a microtubule dynamics inhibitor used to treat certain advanced cancers, including metastatic breast cancer and liposarcoma.
Halaven IV injection 1mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).